Survey

Last month's survey results:

With the recent introduction of 2 new protease inhibitors as adjunctive therapies for the management of hepatitis C, what do you envision your organization's approach will be to managing the use of these products?

a) Selection of 1 preferred product only 16%

b) Maintain both agents on formulary and allow providers to choose 5%

c) Employ prior authorization to validate clinical appropriateness before coverage 24%

d) a & c 16%

d) b & c 39%

With the evolution of the medical home and ACO models of healthcare delivery, what do you see as the most essential means by which pharmacy departments can support the success of such models?

a) More active direct patient outreach, education, and consultation.

b) Enhanced provider education and drug info support.

c) Improved ability to deliver more timely and actionable patient-specific drug alerts to PCPs/care managers.

d) Enhanced mechanisms to monitor and improve patient compliance.

e) More advanced analytics to better risk stratify patients for intervention need.

f) More timely and robust reporting to measure pharmacy-specific quality performance metrics.

Digital Edition

REMS required for belatacept

To confirm your e-newsletter subscription, click here.

To ensure future delivery of email newsletters from Formulary, please take a moment to confirm your subscription by clicking here.
Thank you,
Formulary Staff

CDC revises recommendations
for postpartum contraception

FDA approves new oral antiplatelet agent ticagrelor

FDA has approved ticagrelor (Brilinta, AstraZeneca) tablets to reduce the rate of heart attack (myocardial infarction [MI]) and cardiovascular (CV) death in adult patients with acute coronary syndrome (ACS). Read full article.

FDA approves vaccines for the
2011 to 2012 influenza season

FDA has approved the influenza vaccine formulation for the 2011-2012 vaccine that will be used by the 6 manufacturers licensed to produce and distribute influenza vaccine for the United States. Read full article.

Texting program improves smoking cessation rates

A smoking cessation program in which participants received mobile phone motivational text messages significantly improved smoking cessation rates at 6 months and the method should be considered for inclusion in smoking cessation services, according to a study published June 29 in The Lancet. Read full article.

Error rates for computer-generated prescriptions vary significantly

About 1 in 10 computer-generated prescriptions includes at least 1 error, and one-third of those has potential for harm, which is consistent with the error rate for paper-written prescriptions, according to a new study published online June 29 in the Journal of the American Medical Infomatics Association. Read full article.